ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
5.18
+0.18 (3.60%)
Feb 5, 2025, 10:48 AM EST - Market open
ImmuCell Employees
As of December 31, 2023, ImmuCell had 79 total employees, including 74 full-time and 5 part-time employees. The number of employees increased by 5 or 6.76% compared to the previous year.
Employees
79
Change (1Y)
5
Growth (1Y)
6.76%
Revenue / Employee
$301,747
Profits / Employee
-$48,241
Market Cap
46.16M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ICCC News
- 19 days ago - ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses - GlobeNewsWire
- 26 days ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024 - GlobeNewsWire
- 2 months ago - ImmuCell Corporation (ICCC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 3 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 4 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024 - GlobeNewsWire
- 6 months ago - ImmuCell Corporation (ICCC) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024 - GlobeNewsWire